Hoffmann Karen K

Show results for

Unknown (2)
Genomic (1)
Metabolomics (1)

Repository

dbGaP (1)
MetaboLights (1)

Technology Type

Mass spectrometry (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (1)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2021 (1)

CHEBI ID

CHEBI:16001 (1)
CHEBI:37736 (1)
CHEBI:61553 (1)
CHEBI:67168 (1)
CHEBI:46905 (1)
CHEBI:18066 (1)
CHEBI:18077 (1)
CHEBI:15859 (1)
CHEBI:15729 (1)
CHEBI:17927 (1)
CHEBI:28358 (1)
CHEBI:16284 (1)
CHEBI:30913 (1)
CHEBI:16349 (1)
CHEBI:18307 (1)
CHEBI:17552 (1)
CHEBI:17148 (1)
CHEBI:35619 (1)
CHEBI:16977 (1)
CHEBI:15428 (1)
CHEBI:15713 (1)
CHEBI:16264 (1)
CHEBI:16695 (1)
CHEBI:17659 (1)
CHEBI:27897 (1)
CHEBI:15721 (1)
CHEBI:17858 (1)
CHEBI:16414 (1)
CHEBI:17895 (1)
CHEBI:17295 (1)

Metabolite Name

N(1)-acetylspermidine (1)
L-homocysteine (1)
L-cysteinylglycine (1)
L-alpha-aminobutyric acid (1)
S-adenosyl-L-methioninate (1)
Beta-D-glucose (1)
4-hydroxyproline (1)
L-cystathionine (1)
S-adenosyl-L-homocysteine (1)
5'-S-methyl-5'-thioadenosine (1)
L-gamma-glutamyl-L-cysteine (1)
L-asparagine (1)
Glutathione disulfide (1)
L-cysteine (1)
L-arginine (1)
N(1)-acetylspermine (1)
Spermine (1)
L-serine (1)
L-ornithine (1)
L-lysine (1)
L-alanine (1)
L-valine (1)
L-leucine (1)
L-isoleucine (1)
N-acetylputrescine (1)
Putrescine (1)
Glutathione (1)
L-proline (1)
L-histidine (1)
L-phenylalanine (1)

Release Date

2020 (1)
2019 (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Hepatitis C Antiviral Long-term Treatment Against Cirrhosis (HALT-C)

Reprinted from http://www.haltctrial.org/

Purpose

The Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) Trial is a randomized controlled trial designed to evaluate the safety and efficacy of long-term use of pegylated inte...

phs000430 | dbGaP

SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals

Viruses manipulate cellular metabolism and macromolecule recycling processes like autophagy. Dysregulated metabolism might lead to excessive inflammatory and autoimmune responses as observed in severe and long COVID-19 patients. Here we show that SARS-CoV-2 modulates cellular metabolism and reduces ...

2021-06-11 | MTBLS2840 | MetaboLights

Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.

Not available

S-EPMC6888890 | biostudies-literature

Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans.

Not available

S-EPMC7272903 | biostudies-literature